ESS
45
-2
PCG
72
2
NWL
58
-3
PG
45
-5
GLW
67
3
GME
72
-3
AEE
58
3
APA
48
-4
VLO
48
10
SRE
44
2
KMB
42
-2
OXY
38
-2
AA
76
3
LB
31
-2
SYK
30
2
CINF
66
2
NVDA
49
3
CF
44
-4
COF
67
2
AMP
66
-3
ESS
45
-2
PCG
72
2
NWL
58
-3
PG
45
-5
GLW
67
3
GME
72
-3
AEE
58
3
APA
48
-4
VLO
48
10
SRE
44
2
KMB
42
-2
OXY
38
-2
AA
76
3
LB
31
-2
SYK
30
2
CINF
66
2
NVDA
49
3
CF
44
-4
COF
67
2
AMP
66
-3
Financhill
Back

Columbia Research Enhanced Value ETF Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison

Buy
67

REVS
Columbia Research Enhanced Value ETF

Last Price:
$28.17
Seasonality Move:
1.74%
Sell
41

AMPH
Amphastar Pharmaceuticals, Inc.

Last Price:
$26.58
Seasonality Move:
-3.24%
Buy
67
Columbia Research Enhanced Value ETF (REVS) is a Buy

Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Value ETF [REVS] share price is $28.19. The Score for REVS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • REVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Amphastar Pharmaceuticals, Inc. (AMPH) is a Sell

Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $26.50. The Score for AMPH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • AMPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REVS Stock Price Chart

What is Columbia Research Enhanced Value ETF's stock price today?

  • The Columbia Research Enhanced Value ETF share price today is $28.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing selling pressure, which indicates risk of future bearish movement.

AMPH Stock Price Chart

What is Amphastar Pharmaceuticals, Inc.'s stock price today?

  • The Amphastar Pharmaceuticals, Inc. share price today is $26.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

REVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.02 Buy
Relative Strength Index (14 RSI): 44.53 Sell
Chaikin Money Flow: -13053 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.85 - 28.95) Sell
Bollinger Bands (100): (27.25 - 28.43) Buy

AMPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 52.53 Buy
Chaikin Money Flow: 223954 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.62 - 27.12) Buy
Bollinger Bands (100): (23.99 - 28.89) Buy

REVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.89 Sell
20-day SMA: 28.56 Sell
50-day SMA: 28.2 Sell
200-day SMA: 26.53 Buy
8-day EMA: 11.24 Buy
20-day EMA: 5.16 Buy
50-day EMA: 2.19 Buy
200-day EMA: 0.56 Buy

AMPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.88 Buy
20-day SMA: 26.47 Buy
50-day SMA: 25.5 Buy
200-day SMA: 25.63 Buy
8-day EMA: 26.12 Buy
20-day EMA: 26.19 Buy
50-day EMA: 26.08 Buy
200-day EMA: 27.9 Sell

Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.

Columbia Research Enhanced Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amphastar Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):